Polymerase Chain Reaction (PCR) Market: Introduction
According to the report, the global polymerase chain reaction (PCR) market was valued at US$ 4.1 Mn in 2020 and is projected to expand at a CAGR of 6.4% from 2021 to 2028. Polymerase chain reaction (PCR) is a technique widely used to generate millions or billions of copies or duplicates or half-duplicates of a DNA, allowing researchers to take a small sample of DNA and intensify it (or a portion of it) to an enormous enough amount to concentrate exhaustively. It is used for genetic testing and research, including the examination of archaic DNA samples and the identification of irresistible specialists. PCR is frequently used and critical process in clinical laboratory research for various purposes, including biological research and criminal legal sciences.
Introduction of Advanced Reagents Specific to Type of Test: Key Driver
The introduction of advanced reagents specific to the type of test is expected to boost the global demand for PCR reagents in the near future. PCR reagents include template DNA, PCR primers & probes, dNTPs, PCR buffers, enzymes, and master mixes. PCR consumables mostly include PCR tubes, plates, and other accessories required to conduct PCR reactions. The instruments segment has been split into standard PCR systems, RT PCR systems, and digital PCR systems. The digital PCR systems sub-segment is projected to grow at a rapid pace during the forecast period. This is attributable to advantages of digital PCR systems such as precision, sensitivity, accuracy, reproducibility, direct quantification & multiplexing, and speed of analysis.
Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=830
Rise in Prevalence of Tuberculosis and Other Infectious Diseases: Major Driver
Tuberculosis is one of the most widespread infectious illnesses, with a particularly high prevalence in developing nations. According to the World Health Organization (WHO), an estimated 10 million individuals were infected with tuberculosis globally in 2019. PCR test has been recommended for quick detection of pulmonary tuberculosis, replacing the traditional sputum smear microscopy approach. China, India, and Indonesia are among the countries having a higher prevalence of the disease.
According to the World Health Organization (WHO), herpes simplex virus type 1 infects around 3.7 billion individuals globally. Increase in incidence of various infectious diseases drives demand for diagnostic products, which is expected to propel the market.
Get Report Methodology @ https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=830
Pharmaceutical & Biotechnology Segment to Dominate Polymerase Chain Reaction (PCR) Market
The polymerase chain reaction (PCR) approach has been demonstrated to be effective in pharmaceutical and biotechnology research, as well as microbiological quality control. The approach is also used in genetic engineering. Genetic engineering is the primary driver of the global polymerase chain reaction (PCR) market. It is used to discover genes associated with specific phenotypes, such as genetic illnesses.
Regular testing of raw materials and finished products for microbial contamination is a critical practice in the pharmaceutical & biotechnology industries. In the pharmaceutical industry, sophisticated analytical procedures such as polymerase chain reaction (PCR) have been frequently used for quality control analysis.
Get Custom Research Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=830
Polymerase Chain Reaction (PCR) Market in Asia Pacific to Expand at High CAGR
The global polymerase chain reaction (PCR) market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Molecular diagnosis has transformed modern diagnostic science, and polymerase chain reaction (PCR) has emerged as the method of choice for the early and reliable detection of diseases. Expansion of top manufacturers of PCR products in Asia Pacific through network strengthening and new product launches in developing countries are the key factors expected to drive the PCR market in the region during the forecast period.
Increase in incidence of cancer and infectious diseases has driven the demand for use of the polymerase chain reaction (PCR) technique in clinical diagnosis of these diseases across Asia Pacific. The Korea Central Cancer Registry reported in 2016 that South Korea had 217,057 cancer cases in 2014. According to the WHO, Asia Pacific had the world’s second largest number of HIV-positive people (5.1 million) in 2018. Hence, the region is likely to be the most lucrative market for PCR by 2028.
Key players operating in the global polymerase chain reaction (PCR) market include Bio-Rad Laboratories, Inc., QIAGEN N.V., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc. Becton, Dickinson and Company, Abbott, Siemens Healthcare GmbH (Siemens AG), bioMérieux SA, Danaher Corporation, and Agilent Technologies.
More Trending Reports by Transparency Market Research:
Ketoanalogue for Kidney Disease Market- https://www.prnewswire.com/news-releases/ketoanalogue-for-kidney-disease-market-to-rise-at-a-cagr-of-6-5-during-forecast-period-notes-tmr-study-301617812.html
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.